Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 39

1.

Cost-effectiveness analysis of malaria interventions using disability adjusted life years: a systematic review.

Gunda R, Chimbari MJ.

Cost Eff Resour Alloc. 2017 Jul 1;15:10. doi: 10.1186/s12962-017-0072-9. eCollection 2017. Review.

2.

Seasonal vaccination against malaria: a potential use for an imperfect malaria vaccine.

Greenwood B, Dicko A, Sagara I, Zongo I, Tinto H, Cairns M, Kuepfer I, Milligan P, Ouedraogo JB, Doumbo O, Chandramohan D.

Malar J. 2017 May 2;16(1):182. doi: 10.1186/s12936-017-1841-9. Review.

3.

Immunity as a predictor of anti-malarial treatment failure: a systematic review.

O'Flaherty K, Maguire J, Simpson JA, Fowkes FJI.

Malar J. 2017 Apr 20;16(1):158. doi: 10.1186/s12936-017-1815-y. Review.

4.

The end of a dogma: the safety of doxycycline use in young children for malaria treatment.

Gaillard T, Briolant S, Madamet M, Pradines B.

Malar J. 2017 Apr 13;16(1):148. doi: 10.1186/s12936-017-1797-9. Review.

5.

Safety and benefits of interventions to increase folate status in malaria-endemic areas.

Verhoef H, Veenemans J, Mwangi MN, Prentice AM.

Br J Haematol. 2017 Jun;177(6):905-918. doi: 10.1111/bjh.14618. Epub 2017 Mar 29. Review.

6.

Changing the policy for intermittent preventive treatment with sulfadoxine-pyrimethamine during pregnancy in Malawi.

Mwendera CA, de Jager C, Longwe H, Phiri K, Hongoro C, Mutero CM.

Malar J. 2017 Feb 20;16(1):84. doi: 10.1186/s12936-017-1736-9. Review.

7.

Toxoplasmosis and anti-Toxoplasma effects of medicinal plant extracts-A mini-review.

Al Nasr I, Ahmed F, Pullishery F, El-Ashram S, Ramaiah VV.

Asian Pac J Trop Med. 2016 Aug;9(8):730-4. doi: 10.1016/j.apjtm.2016.06.012. Epub 2016 Jun 28. Review.

8.

Artemisinin-Resistant Plasmodium falciparum Malaria.

Fairhurst RM, Dondorp AM.

Microbiol Spectr. 2016 Jun;4(3). doi: 10.1128/microbiolspec.EI10-0013-2016. Review.

9.

Lessons learnt from 20 years surveillance of malaria drug resistance prior to the policy change in Burkina Faso.

Tinto H, Valea I, Ouédraogo JB, Guiguemdé TR.

Ann Parasitol. 2016;62(1):17-24. doi: 10.17420/ap6201.27. Review.

10.

Subsidising artemisinin-based combination therapy in the private retail sector.

Opiyo N, Yamey G, Garner P.

Cochrane Database Syst Rev. 2016 Mar 9;3:CD009926. doi: 10.1002/14651858.CD009926.pub2. Review.

11.

The influence of pregnancy on the pharmacokinetic properties of artemisinin combination therapy (ACT): a systematic review.

Burger RJ, Visser BJ, Grobusch MP, van Vugt M.

Malar J. 2016 Feb 18;15:99. doi: 10.1186/s12936-016-1160-6. Review.

12.

A systematic review of the efficacy of a single dose artemisinin-naphthoquine in treating uncomplicated malaria.

Naing C, Whittaker MA, Mak JW, Aung K.

Malar J. 2015 Oct 6;14:392. doi: 10.1186/s12936-015-0919-5. Review.

13.

A Systematic Review and Meta-Analysis of the Efficacy of Anti-Toxoplasma gondii Medicines in Humans.

Wei HX, Wei SS, Lindsay DS, Peng HJ.

PLoS One. 2015 Sep 22;10(9):e0138204. doi: 10.1371/journal.pone.0138204. eCollection 2015. Review.

14.

Clinically Available Medicines Demonstrating Anti-Toxoplasma Activity.

Neville AJ, Zach SJ, Wang X, Larson JJ, Judge AK, Davis LA, Vennerstrom JL, Davis PH.

Antimicrob Agents Chemother. 2015 Dec;59(12):7161-9. doi: 10.1128/AAC.02009-15. Epub 2015 Sep 21. Review.

15.

Influence of malaria transmission intensity and the 581G mutation on the efficacy of intermittent preventive treatment in pregnancy: systematic review and meta-analysis.

Chico RM, Cano J, Ariti C, Collier TJ, Chandramohan D, Roper C, Greenwood B.

Trop Med Int Health. 2015 Dec;20(12):1621-33. doi: 10.1111/tmi.12595. Epub 2015 Sep 30. Review.

16.

Antimalarial drugs for preventing malaria during pregnancy and the risk of low birth weight: a systematic review and meta-analysis of randomized and quasi-randomized trials.

Muanda FT, Chaabane S, Boukhris T, Santos F, Sheehy O, Perreault S, Blais L, Bérard A.

BMC Med. 2015 Aug 14;13:193. doi: 10.1186/s12916-015-0429-x. Review.

17.

Antimalarial drug resistance in Africa: key lessons for the future.

Takala-Harrison S, Laufer MK.

Ann N Y Acad Sci. 2015 Apr;1342:62-7. doi: 10.1111/nyas.12766. Review.

19.

The molecular basis of antifolate resistance in Plasmodium falciparum: looking beyond point mutations.

Heinberg A, Kirkman L.

Ann N Y Acad Sci. 2015 Apr;1342:10-8. doi: 10.1111/nyas.12662. Epub 2015 Feb 18. Review.

20.

Primaquine or other 8-aminoquinoline for reducing Plasmodium falciparum transmission.

Graves PM, Gelband H, Garner P.

Cochrane Database Syst Rev. 2015 Feb 19;(2):CD008152. doi: 10.1002/14651858.CD008152.pub4. Review.

Supplemental Content

Loading ...
Support Center